Nektar Therapeutics (NKTR): Q1 EPS of -$0.36 misses by $0.03. Revenue of $17.9M (+58% Y/Y). (PR)

|About: Nektar Therapeutics (NKTR)|By:, SA News Editor
Nektar Therapeutics (NKTR): Q1 EPS of -$0.36 misses by $0.03. Revenue of $17.9M (+58% Y/Y). (PR)